Neuroinflammatory Response and Headache Control in Patients After Subarachnoid Hemorrhage
NCT ID: NCT03604276
Last Updated: 2024-01-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
60 participants
OBSERVATIONAL
2017-12-01
2026-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Percutaneous SPG Block in Aneurysmal SAH
NCT04331938
Neurological Outcome in Patients of Traumatic Subarachnoid Haemorrhage
NCT02073890
Effect of Red Blood Cell Transfusion on Brain Metabolism in Patients With Subarachnoid Hemorrhage
NCT00968227
Platelet Transfusion in Acute Intracerebral Hemorrhage
NCT00699621
Efficacy of Scalp Block in Managing Post Subarachnoid Hemorrhage Headache in Critically Ill Patients. A Single Centre Randomized Controlled Trial
NCT07307508
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \> 18 years
* Treated with external ventricular drainage
Exclusion Criteria
* Age \< 18 years
* Traumatic SAH
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
MaineHealth
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Elizabeth Glisic
Clinical Pharmacist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elizabeth K Glisic, PharmD
Role: PRINCIPAL_INVESTIGATOR
MaineHealth
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maine Medical Center
Portland, Maine, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1100316-599
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.